IMPACT OF AMNOG ON THE COMPARISON OF ORPHAN DRUG PRICES BETWEEN FRANCE AND GERMANY

被引：0
|
作者：
Oku, Y. [1 ]
Fukushima, A. [2 ]
Dorey, J. [2 ]
Toumi, M. [3 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
[2] Creat Ceut, Paris, France
[3] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.346
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP16
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF ADDITIONAL BENEFIT RATING AND DRUG PRICES FOR ORPHAN DRUGS IN FRANCE AND GERMANY
    Oku, Y.
    Fukushima, A.
    Dorey, J.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S107 - S107
  • [2] THE IMPACT OF AMNOG ON DRUG REIMBURSEMENT IN GERMANY
    Heeg, B.
    Schoeman, O.
    Mueller, S.
    Wilke, T.
    VALUE IN HEALTH, 2013, 16 (07) : A459 - A459
  • [3] Determinants of Orphan Drug Prices in Germany
    Franziska Worm
    Charalabos-Markos Dintsios
    PharmacoEconomics, 2020, 38 : 397 - 411
  • [4] Determinants of Orphan Drug Prices in Germany
    Worm, Franziska
    Dintsios, Charalabos-Markos
    PHARMACOECONOMICS, 2020, 38 (04) : 397 - 411
  • [5] IS IT WORTH HAVING ORPHAN DRUG STATUS IN GERMANY POST-AMNOG?
    Radicek, S.
    Obradovic, M.
    Rauland, M.
    VALUE IN HEALTH, 2013, 16 (07) : A391 - A391
  • [6] IMPACT OF THE GERMAN AMNOG EVALUATION ON DRUG PRICES: CORRELATION OF REBATE?
    Neeser, K.
    Loeffler, D.
    Schmidt, E.
    Muller, E.
    VALUE IN HEALTH, 2013, 16 (07) : A473 - A473
  • [7] DETERMINANTS OF ORPHAN DRUG PRICES IN FRANCE: REGRESSION ANALYSIS
    Korchagina, D.
    Vataire, A.
    Toumi, M.
    Falissard, B.
    Aballea, S.
    VALUE IN HEALTH, 2015, 18 (07) : A337 - A337
  • [8] HTA ASESSMENT COMPARISON OF ORPHAN DRUGS IN FRANCE AND GERMANY
    Remuzat, C.
    Mzoughi, O.
    Rodrigues, J.
    Korchagina, D.
    Toumi, M.
    VALUE IN HEALTH, 2014, 17 (03) : A236 - A237
  • [9] COMPARISON OF ORPHAN DRUG PRICES: BELGIUM VS LUXEMBOURG
    Chachoua, L.
    Hanna, E.
    Dussart, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S463 - S463
  • [10] COMPREHENSIVE REVIEW OF ORPHAN DRUGS POST-AMNOG IN GERMANY
    Leibfried, M. J.
    Jun, K.
    Neuner, C.
    Arsiwalla, M. Y.
    Richardson, S. K.
    VALUE IN HEALTH, 2015, 18 (07) : A681 - A681
12345